Clinical Trial Update: NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating NCPAP plus heliox for infant respiratory distress syndrome has completed. The study also considers bronchopulmonary dysplasia as a re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Respiratory Distress Syndrome, Bronchopulmonary Dysplasia | Phase 2 | Status: COMPLETED